$PAHC

PHIBRO ANIMAL HEALTH CORP

Insider trades

No enriched coverage for $PAHC in the last 7 days.

No SEC Form 4 filings for $PAHC in the last 30 days.

See all $PAHC insider activity →
Med

PHIBRO ANIMAL HEALTH CORP (PAHC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

PHIBRO ANIMAL HEALTH CORP (PAHC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001069899 0001069899 2026-06-25 2026-06-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report

Why Phibro Animal Health (PAHC) Stock Is Trading Up Today

Phibro Animal Health (NASDAQ:PAHC) shares rose 10.2% in the afternoon after director E. Thomas Corcoran bought $317,700 of stock on May 29: 10,000 shares at a weighted average $31.77. His holdings increased to 41,459 shares, according to the report. The stock is down 15.7% YTD at $31.43.

PAHC sentiment & insider activity

Recent PAHC coverage spans financial news, corporate actions and insider activity.

What's driving PAHC

  • New CEO appointment plus detailed equity-compensation mechanics can shift near-term sentiment and valuation expectations, but it’s not a fundamental operating update.

    SEC EDGAR 8-K · Jun 26, 2026

  • Insider buying is being treated as a near-term confidence signal, driving a sharp positive tape reaction.

    finance.yahoo.com · Jun 4, 2026

  • Insider open-market buying can be a modest bullish signal, but it is not a fundamental catalyst by itself.

    SEC EDGAR · Jun 2, 2026

  • Phibro Animal Health Corporation's participation in the upcoming healthcare conference suggests increased visibility and potential positive investor sentiment. The company's key executives will address analysts and investors, which may lead to short-term stock movement.

    Business Wire · May 8, 2026

  • Phibro Animal Health (PAHC) is highlighted as a top value stock for long-term investment, supported by favorable valuation metrics and growth prospects in the animal health sector.

    Zacks Commentary · Nov 27, 2025

alphai scores every news story that mentions PAHC with an AI model for sentiment and relevance, and aggregates insider trades from PHIBRO ANIMAL HEALTH CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $PAHC

Score
$PAHCMed

PHIBRO ANIMAL HEALTH CORP (PAHC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

PHIBRO ANIMAL HEALTH CORP (PAHC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001069899 0001069899 2026-06-25 2026-06-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report

$PAHCMedAI 8/10

Why Phibro Animal Health (PAHC) Stock Is Trading Up Today

Phibro Animal Health (NASDAQ:PAHC) shares rose 10.2% in the afternoon after director E. Thomas Corcoran bought $317,700 of stock on May 29: 10,000 shares at a weighted average $31.77. His holdings increased to 41,459 shares, according to the report. The stock is down 15.7% YTD at $31.43.

Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference

Phibro Animal Health Corporation announced its participation in the Bank of America Securities Health Care Conference. Key executives, including Daniel Bendheim, Larry Miller, and Glenn David, will address financial analysts and investors on May 13, 2026, at 1:40 PM ET. A live audio presentation and replay will be available on the company's Investor Relations Website.

Related tickers